Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve posted strong revenue increases but also a decline in profit in 2007.
IBA enjoyed sales growth of 25%, from 170.2 million euros ($261.5 million U.S.) in 2006 to 213.8 million euros ($328.5 million) in 2007. But income for the period was down 53%, from 30 million euros ($46 million) in 2006 to 13.9 million euros ($21.3 million) in 2007.
Related Reading
IBA inks French particle-beam therapy deal, February 7, 2008
IBA finalizes proton therapy deal, December 21, 2007
FDA OKs Compass dosimetry device, December 18, 2007
IBA sells cyclotron to Saudi Arabia, December 4, 2007
IBA, PETLinQ acquire SourceMedical's radiology division, November 26, 2007
Copyright © 2008 AuntMinnie.com
